文献速递主动脉外科

降主动脉假腔通畅的Stanford A型急性主动脉夹层患者的最佳手术策略是什么

What is the optimal surgical strategy for Stanford Type A acute aortic dissection in patients with a patent false lumen at the descending aorta?
PubMed 文献 · Eur J Cardiothorac Surg · 2018-01-01

该回顾性研究纳入290例降主动脉假腔通畅的Stanford A型急性主动脉夹层患者,分为非全主动脉弓置换组(n=124)和全主动脉弓置换组(n=166)。两组院内死亡率无显著差异(13% vs 10%,P=0.45),全主动脉弓置换组远端主动脉扩张≥50 mm的免除率显著更高(P=0.03)。作者认为积极切除破口并提高全主动脉弓置换率的手术策略可接受,对此类患者应考虑全主动脉弓置换以预防远端主动脉未来扩张。

要点

  • 降主动脉假腔通畅的Stanford A型急性主动脉夹层患者中,全主动脉弓置换组与非全主动脉弓置换组院内死亡率无显著差异(13% vs 10%,P=0.45)。
  • 全主动脉弓置换组远端主动脉扩张≥50 mm的免除率显著高于非全主动脉弓置换组(P=0.03)。
  • 非全主动脉弓置换组是远端主动脉扩张>50 mm的独立预测因素(P=0.01;HR 3.1,95%CI 1.28-8.05)。

核心结论

  • 作者认为,积极切除破口并提高全主动脉弓置换率的手术策略可接受,对降主动脉假腔通畅的患者应考虑全主动脉弓置换以预防远端主动脉未来扩张。

研究设计与样本

  • 回顾性研究,纳入近20年因Stanford A型急性主动脉夹层接受急诊手术的518例患者中290例术前降主动脉假腔通畅者,分为非全主动脉弓置换组(n=124;68±14岁)和全主动脉弓置换组(n=166;61±13岁)。

主要发现

  • 院内死亡率为11%(32/290),两组无显著差异(非全主动脉弓置换组13% vs 全主动脉弓置换组10%,P=0.45)。
  • 整个降主动脉假腔血栓形成率非全主动脉弓置换组为32%,全主动脉弓置换组为41%(P=0.16)。
  • 全主动脉弓置换组远端主动脉扩张≥50 mm的免除率显著高于非全主动脉弓置换组(P=0.03)。
  • 远端主动脉扩张>50 mm的独立预测因素包括非全主动脉弓置换组(P=0.01;HR 3.1,95%CI 1.28-8.05)和未实现原发破口切除(P=0.002;HR 6.2,95%CI 1.38-8.66)。

关键数值与推荐

  • 降主动脉假腔通畅的Stanford A型急性主动脉夹层患者中,全主动脉弓置换组远端主动脉扩张≥50 mm的免除率显著高于非全主动脉弓置换组(P=0.03)。
  • 非全主动脉弓置换组远端主动脉扩张>50 mm的风险约为全主动脉弓置换组的3.1倍(HR 3.1,95%CI 1.28-8.05;P=0.01)。
  • 未实现原发破口切除者远端主动脉扩张>50 mm的风险约为实现破口切除者的6.2倍(HR 6.2,95%CI 1.38-8.66;P=0.002)。

临床怎么用

  • 作者认为,对降主动脉假腔通畅的Stanford A型急性主动脉夹层患者,应考虑全主动脉弓置换以预防远端主动脉未来扩张。
  • 作者认为,积极切除破口并提高全主动脉弓置换率的手术策略可接受。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Aggressive total arch replacement (TAR) to obtain thrombosis of the distal false lumen (FL) in patients with Stanford Type A acute aortic dissection, particularly with a patent FL at the descending aorta, is discussed. The aim of this study was to examine the efficacy of our strategy. METHODS: In the last 20 years, we retrospectively reviewed the records of 518 patients with Type A acute aortic dissection who underwent an emergent surgery. Among them, 290 patients with a preoperative patent FL at the descending aorta were enrolled in this study. Patients were divided in 2 groups: the non-TAR group (n = 124; 68 ± 14 years) and the TAR group (n = 166; 61 ± 13 years). RESULTS: In-hospital mortality was 11% (32/290) without significant difference between the 2 groups (the non-TAR group 13% vs the TAR group 10%, P = 0.45). The rates of FL thrombosis of the entire descending aorta were detected at 32% in the non-TAR group and 41% in the TAR group (P = 0.16). Freedom from distal aortic dilatation ≥50 mm was significantly higher in the TAR group (P = 0.03) than in the non-TAR group. Independent predictors of distal aortic dilatation >50 mm were patients in the non-TAR group (P = 0.01; hazard ratio 3.1, 95% confidence interval 1.28-8.05) and unachieved primary entry tear resection (P = 0.002; hazard ratio 6.2, 95% confidence interval 1.38-8.66). CONCLUSIONS: Our surgical strategy with an aggressive entry resection with higher rate of TAR was acceptable. In patients with a patent FL at the descending aorta, TAR should be considered to prevent the future growth of the distal aorta.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Inoue Y, Matsuda H, Omura A, et al. What is the optimal surgical strategy for Stanford Type A acute aortic dissection in patients with a patent false lumen at the descending aorta? Eur J Cardiothorac Surg. 2018. PMID: 29608664. doi:10.1093/ejcts/ezy125

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。